Press Releases
FDA Grants Orphan Drug Status for CF102 for the Treatment of Hepatocellular Carcinoma to Can-Fite BioPharma
Can-Fite BioPharma Ltd , a biotechnology company developing small molecule drugs for the treatment of inflammatory, and liver diseases, traded on the Tel Aviv Stock Exchange, announced today that the US Food and Drug Administration has granted Orphan...
Press Releases
ELC Group launches new software subsidiary Pharma eReport to provide complete EVMPD compliance solution
ELC Group, the pan-European pharmaceutical regulatory affairs organisation, today announces the launch of a new subsidiary, Pharma eReport – a software and services company that delivers a comprehensive EVMPD compliance solution for pharmaceutical regulatory professionals. ...
Press Releases
Provepharm announces impressive trading and financial results for 2011
Provepharm, which is specialized in the development of pharmaceutical applications, announces today very healthy trading and financial results for 2011. The company broke even for the first time last year, when its revenues amounted to EUR three million. ...
Press Releases
DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference
DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be an invited speaker at the upcoming “The Future of Genomic Medicine...
Press Releases
Ferrer announces best-in-class results in phase I for Lorediplon in insomnia
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, today announces that it has completed phase I clinical trials of Lorediplon in insomnia. The trials demonstrated the orally available compound has a best-in-class...
Press Releases
Pharmaceutical regulatory affairs specialist ELC Group establishes global HQ in Cambridge, UK
Cambridge, UK, February 8 2012 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today formally announces that it has established its global headquarters in Cambridge, UK. The opening of the new global HQ follows a year of...
Press Releases
RBCC Negotiates Funding Terms With n3D
Rainbow Biosciences, the biotech division of Rainbow Coral Corp. announced today that it’s on the cusp of a major breakthrough in its business relationship with n3D Biosciences. Last week, management from RBCC and n3D convened to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read